Add a listing
    Add a listing

    Cleara Biotech

      targeting cellular senescence to extend human health span. (FOXO4 pathway, peptides)

    General
    • Headquarters

      Utrecht, Utrecht, Netherlands

    • Founders & Team

      Peter de. Keizer, Tobias Madl, Marco Demaria

    • Year Founded

      2018

    • Company type

      Private company

    • Funding stage

      Seed

    • Investors

      Apollo Health Ventures

    Technical Details
    • Aging Target

      Cellular senescence

    • Product modality

      peptide

    • Clinical stage

      Pre-clinical

    About

    At Cleara Biotech, we are highly motivated to develop safe and effective treatments to counter the negative aspects of aging and target diseases like therapy-resistant late stage cancer. We aim to do so by generating compounds that are capable of selectively eliminating senescent and senescent-like cancer cells. Cleara Biotech is the exciting result of a long and proven academic history of the key members of our scientific team

    How much is an extra decade of life worth to you? Make a bet on longevity science today.

    Donate to Impetus Grants

    You May Also Be Interested In